RE:SEC 10Q reports Phillips recall and OIG ( in limbo )Already addressed by IR, jackass.....
Viemed’s revenue from that segment of their business is about 7-8% of total revenue and they do not see this having a material financial impact or any type of inconvenience to the business. We’re still in the early stages and as more information becomes available, management will have more to say. Also, from what we understand, Philips will be using all their inventory to replace the machines and be on the hook for any associated costs.
-Stefan
(905) 326-1888 x60